Chlamydia Species Infect Human Vascular Endothelial Cells and Induce Procoagulant Activity

Journal of Investigative Medicine

Volumn 45, Issue 4, 1997, Pages 168-174

  Fryer, Richard H ^a   Schwobe, Eric P ^a   Woods, Marion L ^a   Rodgers, George M ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

Chlamydia; Endothelium; Platelets; Thromboplastin; Thrombosis

Indexed keywords

CHLAMYDIA; CHLAMYDOPHILA PNEUMONIAE;

THROMBOPLASTIN;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; CYTOLOGY; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; THROMBOCYTE ADHESIVENESS; TIME; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

CELLS, CULTURED; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; ENDOTHELIUM, VASCULAR; HUMANS; PLATELET ADHESIVENESS; THROMBOPLASTIN; TIME FACTORS; UMBILICAL VEINS;

EID: 0031110982     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Visser MR, Vercellotti GM. Herpes simplex virus and atherosclerosis. Eur Heart J 1993;14 (K Suppl):39-41.
2. Speir E, Modali R, Huang E-S, Leon MB, Shawl F, Finkel T, Epstein SE. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994;265:391-4.
3. Paunio K, Impivaara O, Tiekso J, Mäki J. Missing teeth and ischaemic heart disease in men aged 45-65 years. Eur Heart J 1993;14 (K Suppl):54-6.
4. Saikku P, Mattilla K, Nieminen MS, Huttunen JK, Leinonen M, Ekman M-R, Mäkelä PH, Valtonen V. Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;2:983-6.
5. Saikku P, Leinonen M, Tenkanen L, Linnanmäki E, Ekman M-R, Manninen V, Mänttäri M, Frick MH, Huttunen JK. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study. Ann Intern Med 1992;116:273-8.
6. Melnick SL, Shahar E, Folsom AR, Grayston JT, Sorlie PD, Wang S-P, Szklo M. Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Am J Med 1993;95:499-504.
7. Thom DH, Grayston JT, Siscovick DS, Wang S-P, Weiss NS, Daling JR. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 1992;268:68-72.
8. Shor A, Kuo C-C, Patton DL. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J 1992;82:158-61.
9. Kuo C-C, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993;167:841-9.
10. Kuo C-C, Grayston JT, Campbell LA, Goo YA, Wissler RW, Benditt EP. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci USA 1995;92:6911-4.
11. Grayston JT, Kuo C-C, Wang SP, Altman J. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med 1986;315:161-8.
12. Grayston JT, Campbell LA, Kuo C-C, Mordhorst CH, Saikku P, Thom DH, Wang S-P. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 1990;161:618-25.
13. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-9.
14. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria. J Clin Invest 1973;52:2745-56.
15. Fryer RH, Wilson BD, Gubler DB, Fitzgerald LA, Rodgers GM. Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Arterioscler Thromb Vasc Biol 1993;13:1327-33.
16. Weis JR, Pitas RE, Wilson BD, Rodgers GM. Oxidized low-density lipoprotein increases human endothelial cell tissue factor activity and reduces protein C activation. FASEB J 1991;5:2459-65.
17. Caldwell, HD, Kromhout J, Schachter J. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun 1981;31:1161-76.
18. Hatch TP, Miceli M, Silverman JA. Synthesis of protein in host-free reticulate bodies of Chlamydia psittaci and Chlamydia trachomatis. J Bacteriol 1985;162:938-42.
19. Mayer J, Woods ML, Vavrin Z, Hibbs JB. Gamma interferon-induced nitric oxide production reduces Chlamydia trachomatis infectivity in McCoy cells. Infect Immun 1993;61:491-7.
20. Rodgers GM, Kane WH. Activation of endogenous Factor V by a homocysteine-induced vascular endothelial cell activator. J Clin Invest 1986;77:1909-16.
21. Stern DM, Bank I, Nawroth PP, Cassimeris J, Kisiel W, Fenton JW, Dinarello C, Chess L, Jaffe EA. Self-regulation of procoagulant events on the endothelial cell surface. J Exp Med 1985;162:1223-35.
22. Key NS, Vercelotti GM, Winkelmann JC, Moldow CF, Goodman JL, Esmon NL, Esmon CT, Jacob HS. Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression. Proc Natl Acad Sci USA 1990;87:7095-9.
23. Drake TA, Rodgers GM, Sande MA. Tissue factor is a major stimulus for fibrin deposition in vegetations of enterococcal endocarditis in the rabbit. J Clin Invest 1984;73:1750-3.
24. Colucci M, Balconi G, Lorenzet R, Pietra A, Locati D, Donati MB, Semeraro N. Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest 1983;71:1893-6.
25. Nemerson Y. Tissue factor and hemostasis. Blood 1988;71:1-8.
26. Muhlestein JB, Hammond EH, Carlquist JF, Radicke E, Thomson MJ, Karagounis LA, Woods ML, Anderson JL. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J am Coll Cardiol 1996;27:1555-61.